Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome

• Status: Withdrawn
• Trial end date: 2019-01-31
• Target enrollment: 0
• Participant gender: Female

Summary

We will get the impact of mirabegron on psychological distress, urethra and bladder blood flow and c reactive protein.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Far Eastern Memorial Hospital
• Treatments: Mirabegron

Criteria

Inclusion Criteria:

• All OAB female patients

• >20 years

Exclusion Criteria:

• Allergy to mirabegron, urinary tract infections